BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8354094)

  • 1. [Prognostic factors of endometrial carcinoma: a study of 98 cases].
    Yin LJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
    Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
    Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
    Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
    Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
    Lei X; Shan JL; Tang C; Zhao KW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy for stage I, grade 2 endometrial adenocarcinoma and adenoacanthoma with limited myometrial invasion.
    Fanning J; Evans MC; Peters AJ; Samuel M; Harmon ER; Bates JS
    Obstet Gynecol; 1987 Dec; 70(6):920-2. PubMed ID: 3120068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
    De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
    Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical observation of young, middle-aged and elderly women with endometrial carcinoma].
    Dai FR; Peng GQ; Zhang Y; Chen CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):690-3. PubMed ID: 16708811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histology and prognosis of endometrial carcinoma].
    Sakamoto A; Hirai Y; Yamauchi K; Kitagawa T; Sugano H; Masubuchi K; Hasumi K
    Gan No Rinsho; 1987 Dec; 33(15):1897-900. PubMed ID: 3430742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of the pathologic findings in endometrial cancer.
    Christopherson WM
    Clin Obstet Gynaecol; 1986 Dec; 13(4):673-93. PubMed ID: 3024898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
    Murray SK; Young RH; Scully RE
    Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic modalities of endometrial carcinoma in stage I and II].
    Sun J; Sheng X; Chou Z
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):601-4. PubMed ID: 9642376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.